1. Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments;Dawidczyk;Front. Chem.,2014
2. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status;van der Meel;Adv. Drug Deliv. Rev.,2013
3. ASHP Foundation report;Www.ashpfoundation.org;Am. J. Health Syst. Pharm.,1995
4. Quadrupole stimuli-responsive targeted polymeric nanocontainers for cancer therapy: artificial intelligence in drug delivery systems;Kordas,2022
5. Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier;Caraglia;Curr. Cancer Drug Targets,2012